Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Postmenopausal Women With Primary Breast Cancer
NCT00237224Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2003
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of letrozole in breast cancer, sponsored by Novartis. Started Feb 2003; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00237224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237224.